BlueOcean Ventures II, a tokenized medtech venture capital fund backed by Swiss-based VC firm BlueOcean Ventures, recently announced the launch SwissVCToken, the security token offering (STO) platform developed for the sale of the fund’s BOV Token, according to a press release seen by Cryptovest. BlueOcean Ventures II is the second fund of the VC firm. It focuses on startups and companies that manufacture and/or distribute medical devices and life science products. The fund aims to support innovations that increase quality of life and improve health.
The VC fund will use the STO platform to sell its BOV token, which is backed by real-world assets and the price of which derives from the value of the companies included in the fund’s portfolio. The BOV Token will enable professional and accredited investors to indirectly generate investment returns from the fund’s portfolio startups at their early stage. So far, BlueOcean Ventures II invested in five medtech startups: Ava, Volumina Medical, Rheon Medical, Luciole Medical, and Abionic. Soon, the fund will add more firms, aiming to reach up to 12 companies. The fund is allowing its investors to buy the tokens with both cryptocurrency (BTC and ETH) and fiat money (CHF and USD).
Emmanuel de Watteville, general partner and co-founder of BlueOcean Ventures ll, commented...
This article appeared first on Cryptovest
